Lian Po Yin Granule
Natural health product licensed in Canada
If this product were sold in France
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Coptis chinensis Source : Coptis deltoidea - rhizome Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 750 mg | 50 mg | Not calculated |
| Coptis chinensis Source : Coptis teeta - rhizome Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 750 mg | 50 mg | Not calculated |
| Coptis chinensis Source : Coptis chinensis - Rhizome Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 750 mg | 50 mg | Not calculated |
| Magnolia officinalis Source : Magnolia officinalis var. biloba - Tige écorce Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 1,500 mg | 100 mg | Not calculated |
| Gardenia jasminoides Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 2,250 mg | 150 mg | Not calculated |
| Glycine max Source : Glycine max - Graine Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 2,250 mg | 150 mg | Not calculated |
| Acorus gramineus Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 750 mg | 50 mg | Not calculated |
| Pinellia ternata Source : Pinellia ternata - Rhizome Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 750 mg | 50 mg | Not calculated |
| Phragmites australis Extract : Matériel brut sec Extraction ratio : 40:1 Dry plant equivalent : 15,000 mg | 375 mg | Not calculated |
Non-medicinal ingredients
Dextrine, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Portions | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Combination of Traditional Chinese Medicine Ingredients. Traditional Chinese Medicine used to clear Heat, transform Dampness, regulate the Qi, and harmonize the middle burner.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- Cyctek Lian Po Yin Granule
- Licence holder
- CycTek Inc.
- NPN or DIN-HM
- 80129385
- Status
- Active licence
- Licence date
- 6 February 2024
- Revision date
- Not provided
- Form
- Granules
- Route of administration
- Orale
- Application type
- Traditionnelle
Source
Official Health Canada record, licence 80129385
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Glycine max
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Lian Po Yin Granule”, https://compoatlas.com/en/supplements/canada/80129385-lian-po-yin-granule, updated 6 February 2024.